Hu proteins as novel splicing regulators in neurons
Hu 蛋白作为神经元中新型剪接调节因子
基本信息
- 批准号:7252680
- 负责人:
- 金额:$ 26.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:Alternative SplicingAntigensBindingBinding SitesBiological AssayBrainCalcitoninCalcitonin Gene-Related PeptideCellsComputer SimulationDatabasesDevelopmentDiseaseDrosophila Sxl proteinDrosophila genusElementsEventExonsFamilyFutureGene TargetingGenesGenetic VariationGenomicsGoalsHeterogeneous Nuclear RNAHomologous GeneHu antigenHuman calcitoninImmune SeraIn Situ HybridizationIn VitroIntronsMessenger RNAMetabolismMethodsNervous system structureNeurofibromatosis 1NeurologicNeuronal DifferentiationNeuronsNuclear ExtractPathogenesisPatientsProcessProtein BindingProteinsRNARNA ProcessingRNA SplicingRNA-Binding ProteinsRattusRoleScreening procedureSyndromeTestingTransfectionTranslationsUrsidae FamilyWorkbasein vivoinsightlung small cell carcinomamRNA PrecursormRNA Stabilitynervous system disordernovelprotein functionresearch study
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of this project is to investigate a novel function of the Hu family of paraneoplastic neurological disease (PND) antigens in neurons as alternative splicing regulators. Hu proteins belong to a group of neuronal RNA-binding proteins that were cloned using antiserum from PND patients and are antigens of the Hu syndrome triggered by small cell lung carcinomas. Similar to their closest Drosophila homolog ELAV, Hu proteins were shown to be required for neuronal differentiation in the mammalian nervous system. However, the function of Hu proteins as RNA-binding proteins is not understood. Except for a handful of examples indicating that they bind to the AU-rich element of 3'-untanslated region of mRNA to regulate mRNA stability and translation, the in vivo targets of Hu proteins are largely unknown. Recently we have identified two RNA targets for Hu proteins and provided compelling evidence for a prominent role of these proteins as alternative splicing regulators. To characterize the novel function of Hu proteins as splicing regulators in neurons, we propose three specific aims. In aims I and II, we will study the mechanisms that control the neuron-specific alternative RNA processing of the two newly identified Hu target-containing pre-mRNAs by Hu proteins. Specific hypotheses regarding the function of Hu proteins will be generated and tested with both in vitro and in vivo experiments. In aim III, we will identify additional neuronal targets bound by Hu proteins using both in silico database screening and genomic SELEX approaches. The identification of these novel targets will provide the basis for future work that will focus on universality of the principle developed in the proposed studies. These studies will provide not only significant insights into the role of Hu proteins in the development and function of neurons, but also important hints of pathogenesis of the PND disease, the Hu syndrome. Finally, these studies will also greatly increase our understanding of the mechanisms controlling alternative splicing in neurons.
描述(由申请人提供):该项目的长期目标是研究Hu家族的副肿瘤神经疾病(PND)抗原在神经元中作为替代剪接调节因子的新功能。Hu蛋白属于用PND患者抗血清克隆的一组神经元rna结合蛋白,是由小细胞肺癌引发的Hu综合征的抗原。与果蝇的近亲ELAV相似,Hu蛋白被证明是哺乳动物神经系统中神经元分化所必需的。然而,Hu蛋白作为rna结合蛋白的功能尚不清楚。除了少数例子表明它们与mRNA的3'-非翻译区富含au的元件结合以调节mRNA的稳定性和翻译外,Hu蛋白的体内靶点在很大程度上是未知的。最近,我们已经确定了Hu蛋白的两个RNA靶点,并为这些蛋白作为替代剪接调节因子的突出作用提供了令人信服的证据。为了描述Hu蛋白作为神经元剪接调节因子的新功能,我们提出了三个具体目标。在目的I和II中,我们将研究Hu蛋白控制两种新发现的含Hu靶标前mrna的神经元特异性替代RNA加工的机制。关于Hu蛋白功能的具体假设将产生并通过体外和体内实验进行验证。在aim III中,我们将使用计算机数据库筛选和基因组SELEX方法确定由Hu蛋白结合的其他神经元靶点。这些新目标的确定将为今后的工作提供基础,这些工作将侧重于拟议研究中制定的原则的普遍性。这些研究不仅将为胡蛋白在神经元发育和功能中的作用提供重要的见解,而且还将为PND疾病胡综合征的发病机制提供重要线索。最后,这些研究也将大大增加我们对控制神经元选择性剪接机制的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HUA LOU其他文献
HUA LOU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HUA LOU', 18)}}的其他基金
Hu proteins as novel splicing regulators in neurons
Hu 蛋白作为神经元中新型剪接调节因子
- 批准号:
8492172 - 财政年份:2004
- 资助金额:
$ 26.84万 - 项目类别:
Hu proteins as novel splicing regulators in neurons
Hu 蛋白作为神经元中新型剪接调节因子
- 批准号:
8286996 - 财政年份:2004
- 资助金额:
$ 26.84万 - 项目类别:
Hu proteins as novel splicing regulators in neurons
Hu 蛋白作为神经元中新型剪接调节因子
- 批准号:
6895448 - 财政年份:2004
- 资助金额:
$ 26.84万 - 项目类别:
Hu proteins as novel splicing regulators in neurons
Hu 蛋白作为神经元中新型剪接调节因子
- 批准号:
7812578 - 财政年份:2004
- 资助金额:
$ 26.84万 - 项目类别:
Hu proteins as novel splicing regulators in neurons
Hu 蛋白作为神经元中新型剪接调节因子
- 批准号:
8015984 - 财政年份:2004
- 资助金额:
$ 26.84万 - 项目类别:
Hu proteins as novel splicing regulators in neurons
Hu 蛋白作为神经元中新型剪接调节因子
- 批准号:
7886117 - 财政年份:2004
- 资助金额:
$ 26.84万 - 项目类别:
Hu proteins as novel splicing regulators in neurons
Hu 蛋白作为神经元中新型剪接调节因子
- 批准号:
7082879 - 财政年份:2004
- 资助金额:
$ 26.84万 - 项目类别:
Hu proteins as novel splicing regulators in neurons
Hu 蛋白作为神经元中新型剪接调节因子
- 批准号:
6812519 - 财政年份:2004
- 资助金额:
$ 26.84万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Lymph node-targeted codelivery of albumin-binding peptide antigens and di-adjuvant for melanoma combination immunotherapy
用于黑色素瘤联合免疫治疗的白蛋白结合肽抗原和双佐剂的淋巴结靶向共递送
- 批准号:
10522591 - 财政年份:2022
- 资助金额:
$ 26.84万 - 项目类别:
Lymph Node-Targeted Codelivery of Albumin-Binding Peptide Antigens and Di-Adjuvant for Melanoma Combination Immunotherapy
用于黑色素瘤联合免疫治疗的白蛋白结合肽抗原和双佐剂的淋巴结靶向共递送
- 批准号:
10884052 - 财政年份:2022
- 资助金额:
$ 26.84万 - 项目类别:
Identification of novel tumor antigens binding to canine HSP70, and their application to tumor immunotherapy
与犬HSP70结合的新型肿瘤抗原的鉴定及其在肿瘤免疫治疗中的应用
- 批准号:
17K08108 - 财政年份:2017
- 资助金额:
$ 26.84万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Allosteric Binding in Antibodies and Protein Antigens
抗体和蛋白质抗原的变构结合
- 批准号:
7684654 - 财政年份:2008
- 资助金额:
$ 26.84万 - 项目类别:
Allosteric Binding in Antibodies and Protein Antigens
抗体和蛋白质抗原的变构结合
- 批准号:
8131731 - 财政年份:2008
- 资助金额:
$ 26.84万 - 项目类别:
Allosteric Binding in Antibodies and Protein Antigens
抗体和蛋白质抗原的变构结合
- 批准号:
7499132 - 财政年份:2008
- 资助金额:
$ 26.84万 - 项目类别:
Allosteric Binding in Antibodies and Protein Antigens
抗体和蛋白质抗原的变构结合
- 批准号:
7920187 - 财政年份:2008
- 资助金额:
$ 26.84万 - 项目类别:
Innate Cellular Lectin-Mediated Binding of Xenogeneic Antigens
先天细胞凝集素介导的异种抗原结合
- 批准号:
7282042 - 财政年份:2005
- 资助金额:
$ 26.84万 - 项目类别:
Innate Cellular Lectin-Mediated Binding of Xenogeneic Antigens
先天细胞凝集素介导的异种抗原结合
- 批准号:
6984696 - 财政年份:2005
- 资助金额:
$ 26.84万 - 项目类别:
Innate Cellular Lectin-Mediated Binding of Xenogeneic Antigens
先天细胞凝集素介导的异种抗原结合
- 批准号:
7484257 - 财政年份:2005
- 资助金额:
$ 26.84万 - 项目类别: